A plain language summary of the MonumenTAL-1 study: talquetamab for relapsed/ refractory multiple myeloma

This Plain Language Summary of Publication article (PLSP) from Future Oncology describes how talquetamab side effects were managed in a study called MonumenTAL-1 in participants with relapsed/refractory multiple myeloma.

Visit the site using this link to read the article.

This PLSP is based on an article called ‘Clinical Management of Patients With Relapsed/Refractory Multiple Myeloma Treated With Talquetamab’ and was published in Clinical Lymphoma, Myeloma & Leukemia.

Visit Clinical Lymphoma, Myeloma & Leukemia using the link to read the original article.

• Bispecific antibody
• clinical trial
• GPRC5D
• lay summary
• plain language summary
• relapsed or refractory multiple myeloma
• side effects
• talquetamab